Circadian Gating of p21-Mediated Quiescence as a Safeguard Against Geroconversion: A Mechanistic Hypothesis

Cellular senescence is a major driver of tissue aging, yet the molecular conditions that determine whether a cell undergoing p21-mediated arrest enters reversible quiescence versus irreversible senescence remain incompletely understood. We propose that the circadian clock creates a physiological time window, defined by BMAL1-driven suppression of mTORC1, in which p21-mediated cell cycle arrest leads to quiescence rather than geroconversion. We term this process circadian gating of quiescence (CGQ). The hypothesis integrates three independently established findings. First, BMAL1 directly suppresses mTORC1 activity in a circadian manner, with activity nadir occurring during the subjective night. Second, p21-mediated arrest in the presence of low mTORC1 activity produces reversible quiescence, while the same arrest with active mTORC1 drives irreversible geroconversion. Third, cellular senescence itself disrupts circadian rhythmicity, creating a self-amplifying feedback loop. Together, these observations predict that circadian disruption systematically shifts p21 arrests from quiescence toward senescence, accelerating tissue aging. We present two testable predictions and a minimal experimental protocol to validate the core prediction. If confirmed, this framework reframes circadian disruption as a proximal mechanism of senescence accumulation and points toward temporal coordination of cell cycle checkpoints as a potential target for anti-aging intervention.